Literature DB >> 21617563

Acute promyelocytic leukemia with complex translocation t(5;17;15)(q35;q21;q22): case report and review of the literature.

Sung Ran Cho1, Seo-Jin Park, Hyon J Kim, Il Joong Park, Jong Rak Choi, Hyun Joo Jung, Jun Eun Park.   

Abstract

The t(15;17)(q22;q21), resulting in PML-RARA fusion gene, is a characteristic chromosomal translocation in acute promyelocytic leukemia (APL). We report a pediatric APL case with a 3-way translocation: t(5;17;15)(q35;q21;q22). Complete blood cell counts of a 12-year-old girl, of pale appearance, showed pancytopenia with increased blasts. Morphology and immunophenotype of the leukemic cells were compatible with APL. Karyotype analysis showed t(5;17;15)(q35;q21;q22) and add(7)(q32). We detected the PML-RARA fusion gene by both reverse transcriptase-polymerase chain reaction and fluorescent in situ hybridization analysis. The patient underwent successful treatment with cytarabine with all-trans retinoic acid and anthracycline-based therapy.

Entities:  

Mesh:

Year:  2011        PMID: 21617563     DOI: 10.1097/MPH.0b013e31820998de

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  2 in total

1.  Current routine practice and clinico-pathological characteristics associated with acute promyelocytic leukemia in Korea.

Authors:  Sunhyun Ahn; Joon Seong Park; Seong Hyun Jeong; Hyun Woo Lee; Jun Eun Park; Mi Hyang Kim; Yang Soo Kim; Ho Sup Lee; Tae Sung Park; Eunkyoung You; Insoo Rheem; Joowon Park; Ji Young Huh; Myung Seo Kang; Sung Ran Cho
Journal:  Blood Res       Date:  2013-03-25

2.  A Novel Three-Colour Fluorescence in Situ Hybridization Approach for the Detection of t(7;12)(q36;p13) in Acute Myeloid Leukaemia Reveals New Cryptic Three Way Translocation t(7;12;16).

Authors:  Abdulbasit Naiel; Michael Vetter; Olga Plekhanova; Elena Fleischman; Olga Sokova; Grigory Tsaur; Jochen Harbott; Sabrina Tosi
Journal:  Cancers (Basel)       Date:  2013-03-11       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.